/주식/STRO
STRO

STRO

USD

Sutro Biopharma Inc. Common Stock

$1.100+0.000 (0.000%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.100

고가

$1.110

저가

$1.030

거래량

0.07M

기업 기본 정보

시가총액

92.2M

산업

생명공학

국가

United States

거래 통계

평균 거래량

1.85M

거래소

NGM

통화

USD

52주 범위

저가 $0.52현재가 $1.100고가 $5.17

관련 뉴스

GlobeNewswire

Sutro Biopharma to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),

더 보기
Sutro Biopharma to Participate in Upcoming Investor Conferences
PR Newswire

New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty

Equity Insider News Commentary – Optimism in the field of oncology is on the rise, thanks to the National Institutes of Health's latest annual...

더 보기
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on Sutro Biopharma, Maintains $2 Price Target

HC Wainwright & Co. analyst Andres Maldonado reiterates Sutro Biopharma with a Neutral and maintains $2 price target.

더 보기
HC Wainwright & Co. Reiterates Neutral on Sutro Biopharma, Maintains $2 Price Target
GlobeNewswire

Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025

SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),

더 보기
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025